Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Frederic, Lamoth"'
Publikováno v:
healthbook TIMES Das Schweizer Ärztejournal Journal Des Médecins Suisses, Vol 12, Iss 1 (2024)
Cryptococcosis represents the third most frequent invasive fungal infection in solid organ transplant (SOT) recipients and is associated with high mortality rates. Its clinical presentation is often insidious making the diagnosis difficult. Treatment
Externí odkaz:
https://doaj.org/article/b67077ed2bb44c1b882a3c84f9a747b0
Autor:
Elisavet Stavropoulou, Anne Huguenin, Giorgia Caruana, Onya Opota, Nancy Perrottet, Dominique S. Blanc, Bruno Grandbastien, Laurence Senn, Pierre-Yves Bochud, Frederic Lamoth
Publikováno v:
Swiss Medical Weekly, Vol 154, Iss 3 (2024)
AIMS OF THE STUDY: Invasive mould infections are life-threatening complications in patients with haematologic cancer and chemotherapy-induced neutropenia. While invasive aspergillosis represents the main cause of invasive mould infections, non-Asperg
Externí odkaz:
https://doaj.org/article/f423fc8e5bad4754855c6ad372bb41f4
Autor:
Jizhou Li, Lola Aubry, Danielle Brandalise, Alix T. Coste, Dominique Sanglard, Frederic Lamoth
Publikováno v:
Microbiology Spectrum, Vol 12, Iss 2 (2024)
ABSTRACTCandida auris is an emerging yeast pathogen of major concern because of its ability to cause hospital outbreaks of invasive candidiasis and to develop resistance to antifungal drugs. A majority of C. auris isolates are resistant to fluconazol
Externí odkaz:
https://doaj.org/article/313ad400663e4b4eb397d9f9bcbeb28b
Autor:
Frederic Lamoth, Thierry Calandra
Publikováno v:
European Respiratory Review, Vol 31, Iss 166 (2022)
Aspergillus species are the most frequent cause of fungal infections of the lungs with a broad spectrum of clinical presentations including invasive pulmonary aspergillosis (IPA) and chronic pulmonary aspergillosis (CPA). IPA affects immunocompromise
Externí odkaz:
https://doaj.org/article/ea5d6ecf49524c80a42073f067ea9109
Autor:
Baudouin Bourlond, Ana Cipriano, Julien Regamey, Matthaios Papadimitriou-Olivgeris, Christel Kamani, Danila Seidel, Frederic Lamoth, Olivier Muller, Patrick Yerly
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
Scedosporium apiospermum associated endocarditis is extremely rare. We report a case of a disseminated S. apiospermum infection with an invasive right atrial mass in a 52-year-old male, 11 months after heart transplantation, referred to our instituti
Externí odkaz:
https://doaj.org/article/197cc21ccaeb4c51b21e83653b3aff5e
Autor:
Jonathan Tschopp, Jean Yannis Perentes, Catherine Beigelman-Aubry, Sabina Berezowska, Alban Lovis, Olivier Spertini, Pierre-Yves Bochud, Frederic Lamoth
Publikováno v:
Medical Mycology Case Reports, Vol 32, Iss , Pp 68-72 (2021)
Hormographiella aspergillata is a rare cause of invasive mold infection, mostly described in patients with hematological malignancies. We describe two cases of invasive H. aspergillata infections in patients with acute myeloid leukemia, successfully
Externí odkaz:
https://doaj.org/article/b970946f130b446392553edac2b16419
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 12 (2022)
ObjectivesThe antifungal susceptibility testing (AFST) of yeast pathogen alerts clinicians about the potential emergence of resistance. In this study, we compared two commercial microdilution AFST methods: Sensititre YeastOne read visually (YO) and M
Externí odkaz:
https://doaj.org/article/87086c1e5c7b499caea6158fa40db133
Autor:
François Danion, Anne Coste, Coralie Le Hyaric, Clea Melenotte, Frederic Lamoth, Thierry Calandra, Dea Garcia-Hermoso, Vishukumar Aimanianda, Fanny Lanternier, Olivier Lortholary
Publikováno v:
Journal of Fungi, Vol 9, Iss 3, p 307 (2023)
Mucormycosis is a rare but life-threatening fungal infection due to molds of the order Mucorales. The incidence has been increasing over recent decades. Worldwide, pulmonary mucormycosis (PM) presents in the lungs, which are the third main location f
Externí odkaz:
https://doaj.org/article/18804955398448c5beb436e25f1c5897
Publikováno v:
Microbiology Spectrum, Vol 9, Iss 3 (2021)
ABSTRACT Candida auris is an emerging yeast pathogen of candidemia with the ability to develop resistance to all current antifungal drug classes. Novel antifungal therapies against C. auris are warranted. NSC319726 is a thiosemicarbazone with an inhi
Externí odkaz:
https://doaj.org/article/10913bc9747a4ad59d96f161587d3353
Autor:
Antonios Kritikos, Frederic Lamoth
Publikováno v:
Critical Care, Vol 25, Iss 1, Pp 1-3 (2021)
Externí odkaz:
https://doaj.org/article/8e7a7e4fcf74437887929021e058d16e